Publication: 2913

Publication: 2913

Combination of dasatinib with chemotherapy in previously untreated core binding factor acute myeloid leukemia: CALGB 10801

PubMed

PMC

QxMD

DOI

Google Scholar

Citation:: Blood Adv vol 4 (4) 696-705

Year:: 2020
Type:: Manuscript
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: collection

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:: 9

Parents:: 2032 2181
Children:: None

Program:: OGC
Primary Committee:: Leukemia
Sec. Committees:

Pharmas:: Bristol Meyers Squibb
Grants:: U10CA180821, U10CA180882, P30CA033572, U10CA180833, U10CA180836, U10CA180850, U10CA180866, U10CA180867

Corr. Author:
Authors:: Guido Marcucci Susan Geyer Kristina Laumann Weiqiang Zhao Donna Bucci Geoffrey L. Uy William Blum Ann-Kathrin Eisfeld Timothy S. Pardee Eunice S. Wang Wendy Stock Jonathan E. Kolitz Jessica Kohlschmidt Krzysztof Mrózek Clara D. Bloomfield Richard M. Stone Richard A. Larson

Networks:: CA043, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY158, LAPS-OH007, NC002, NORTHWELL

Study: CALGB-10801
Multiple Studies, or Legacy Studies in Alliance Study:: CALGB-20202
Phases:: 2, N/A

Keywords:: 20, 25, Clinical Trials and Observations